
NetMed, Inc.
NTMEOTCFinancial Services
$0.00
+$0.00(+0.00%)
Market Cap$140
P/E Ratio—
52W High$0.00001
52W Low$0.00001
NetMed, Inc.(NTME)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · NTME · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2001-12 | 2000-12 | 1999-12 | 1998-12 | 1997-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | 0.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | ($0.00B) | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Operating Income | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | 0.00% | -400.00% | -277.78% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Income Tax Expense | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | — | -600.00% | -650.00% | -366.67% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $0.05 | $-0.05 | $-0.23 | $-0.30 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | -400.00% | -277.78% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B
深入了解NetMed, Inc.
关于NetMed, Inc.(NTME)损益表
NetMed, Inc.(NTME)损益表数据来源于SEC Form 10-K及10-Q申报文件。2001财年,NTME实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.00B)(净利率—)。
常见问题
NTME · 4 问NetMed, Inc.(NTME)2001财年营收为$0.00B,同比down—%。
NTME revenueNTME salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09